1. Home
  2. LCFY vs EVGN Comparison

LCFY vs EVGN Comparison

Compare LCFY & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Locafy Limited

LCFY

Locafy Limited

HOLD

Current Price

$3.75

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.52

Market Cap

7.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCFY
EVGN
Founded
2009
1999
Country
Australia
Israel
Employees
18
N/A
Industry
Agricultural Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
7.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LCFY
EVGN
Price
$3.75
$0.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
15.2K
349.9K
Earning Date
05-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.51
52 Week High
$13.98
$1.50

Technical Indicators

Market Signals
Indicator
LCFY
EVGN
Relative Strength Index (RSI) 53.28 24.70
Support Level $2.72 $0.52
Resistance Level $4.03 $0.86
Average True Range (ATR) 0.30 0.06
MACD 0.05 -0.00
Stochastic Oscillator 91.85 7.75

Price Performance

Historical Comparison
LCFY
EVGN

About LCFY Locafy Limited

Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: